- Cardiac, Anesthesia and Surgical Outcomes
- Hemodynamic Monitoring and Therapy
- Organ Transplantation Techniques and Outcomes
- Liver Disease and Transplantation
- Malaria Research and Control
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Liver Disease Diagnosis and Treatment
- Congenital Heart Disease Studies
- Aortic aneurysm repair treatments
- Cardiac Imaging and Diagnostics
- Viral Infections and Vectors
- Blood groups and transfusion
- Immune Cell Function and Interaction
- Pancreatic function and diabetes
- Diabetes and associated disorders
- Mosquito-borne diseases and control
- Diabetes Management and Research
- Clinical Nutrition and Gastroenterology
Hospital Universitário Walter Cantídio
2022-2024
Universidade Federal do Ceará
2006-2024
Hospital Geral de Fortaleza
2024
Sociedade Brasileira de Cardiologia
2017
Bayer (France)
2017
Sanofi (Mexico)
2017
Roche (Switzerland)
2017
Servier (France)
2017
Ospedale Sant Antonio
2017
Baxter (United States)
2017
1. Definition of the Problem […] 3rd Guideline for Perioperative Cardiovascular Evaluation Brazilian Society Cardiology
Although of great importance for all those involved in liver transplant, literature there is no consensual description on its hemodynamic behavior. This study intends to describe the behavior during and first 48 h after transplant .A prospective consecutive 61 patients was carried out; 50 were male, with average age 49 years (18-70 years). Hemodynamic measurements followed up at beginning surgery, 30 minutes revascularization graft afterwards 6 hours post revascularization. Weight obtained...
Objective: To analyze the effectiveness and safety of two insulin therapy techniques (continuous intermittent infusion) in blood glucose control people who have undergone liver transplantation, immediate postoperative period. Methods: The study was a prospective, open, pragmatic clinical trial with 42 participants, divided into groups 21 patients each, period following transplantation. Participants Experimental Group Control received continuous infusion bolus insulin, respectively, starting at [...]